Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · IEX Real-Time Price · USD
25.57 -0.13 (-0.51%)
Jan 21, 2022 4:00 PM EST - Market closed
Income Statement (Annual)
Millions USD. Fiscal year is Jan - Dec.
| Year | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 198.32 | 175.34 | 164.25 | 154.94 | 133.59 | 99.89 | 28.2 | 0 | 0 |
| Revenue Growth (YoY) | 13.11% | 6.75% | 6.01% | 15.98% | 33.74% | 254.19% | - | - | - |
| Cost of Revenue | 6.13 | 5.23 | 5.53 | 3.61 | 4.55 | 2.19 | 0.57 | 0 | 0 |
| Gross Profit | 192.2 | 170.1 | 158.72 | 151.33 | 129.04 | 97.71 | 27.63 | 0 | 0 |
| Selling, General & Admin | 135.8 | 128.95 | 103.65 | 101.33 | 91.94 | 79.54 | 59.65 | 17.69 | 29.59 |
| Research & Development | 131.77 | 140.96 | 123.76 | 78.17 | 70.82 | 50.43 | 47.8 | 7.08 | 0.66 |
| Other Operating Expenses | 97.13 | 7.5 | -0.24 | 6.23 | 6.11 | 4.71 | 0 | 0 | 0 |
| Operating Expenses | 364.7 | 277.41 | 227.17 | 185.73 | 168.87 | 134.68 | 107.44 | 24.77 | 30.26 |
| Operating Income | -172.51 | -107.31 | -68.45 | -34.4 | -39.83 | -36.97 | -79.81 | -24.77 | -30.26 |
| Interest Expense / Income | 19.05 | 18.83 | 9.81 | 4.42 | 4.73 | 7.75 | 7.44 | 0.05 | 0.08 |
| Other Expense / Income | -2.77 | 20.31 | 23.61 | 19.54 | 13.02 | -150.19 | 26.16 | 9.73 | 0 |
| Pretax Income | -188.79 | -146.45 | -101.87 | -58.36 | -57.58 | 105.47 | -113.4 | -34.55 | -30.34 |
| Income Tax | -19.36 | -0.02 | 0.81 | 1.37 | -9.68 | -11.77 | -2.46 | 0.08 | 0 |
| Net Income | -169.43 | -146.43 | -102.68 | -59.73 | -47.9 | 117.24 | -110.94 | -34.63 | -30.34 |
| Net Income Common | -169.43 | -146.43 | -102.68 | -59.73 | -47.9 | 117.24 | -110.94 | -34.63 | -30.34 |
| Shares Outstanding (Basic) | 48 | 42 | 40 | 39 | 37 | 34 | 25 | 14 | 4 |
| Shares Outstanding (Diluted) | 48 | 42 | 40 | 39 | 38 | 38 | 25 | 14 | 4 |
| Shares Change | 12.28% | 4.72% | 4.29% | 1.26% | 1.88% | 49.98% | 76.40% | 287.90% | - |
| EPS (Basic) | -3.56 | -3.46 | -2.54 | -1.54 | -1.29 | 3.49 | -4.43 | -2.44 | -8.29 |
| EPS (Diluted) | -3.56 | -3.46 | -2.54 | -1.54 | -1.29 | 3.17 | -4.43 | -2.44 | -8.29 |
| Free Cash Flow Per Share | -1.04 | -1.38 | -0.64 | 0.17 | -0.13 | -0.04 | -1.86 | -1.25 | -0.75 |
| Gross Margin | 96.91% | 97.01% | 96.63% | 97.67% | 96.59% | 97.81% | 97.98% | - | - |
| Operating Margin | -86.98% | -61.20% | -41.68% | -22.20% | -29.82% | -37.01% | -282.98% | - | - |
| Profit Margin | -85.43% | -83.51% | -62.51% | -38.55% | -35.86% | 117.36% | -393.36% | - | - |
| Free Cash Flow Margin | -24.96% | -33.31% | -15.64% | 4.21% | -3.64% | -1.41% | -164.92% | - | - |
| Effective Tax Rate | 10.25% | 0.01% | -0.80% | -2.34% | 16.81% | -11.16% | 2.17% | -0.22% | 0.00% |
| EBITDA | -143.95 | -107.16 | -72.93 | -36.14 | -36.71 | 126.61 | -100.56 | -34.29 | -30.13 |
| EBITDA Margin | -72.59% | -61.11% | -44.40% | -23.32% | -27.48% | 126.74% | -356.56% | - | - |
| EBIT | -169.74 | -127.62 | -92.06 | -53.94 | -52.85 | 113.22 | -105.96 | -34.5 | -30.26 |
| EBIT Margin | -85.59% | -72.79% | -56.05% | -34.81% | -39.56% | 113.34% | -375.72% | - | - |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).